Charles Schwab Investment Management Inc. Boosts Stock Position in Phreesia, Inc. (NYSE:PHR)

Charles Schwab Investment Management Inc. boosted its stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 10.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 493,448 shares of the company's stock after purchasing an additional 46,209 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.85% of Phreesia worth $12,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Zacks Investment Management bought a new position in shares of Phreesia during the 3rd quarter worth approximately $631,000. State Street Corp increased its position in shares of Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Wesbanco Bank Inc. lifted its holdings in shares of Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock valued at $1,157,000 after purchasing an additional 20,000 shares during the last quarter. Barclays PLC boosted its position in shares of Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after purchasing an additional 43,225 shares in the last quarter. Finally, Franklin Resources Inc. increased its position in Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after buying an additional 42,973 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Remove Ads

Phreesia Stock Performance

PHR traded up $0.04 on Tuesday, reaching $28.11. The stock had a trading volume of 385,145 shares, compared to its average volume of 416,950. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The business's 50-day moving average price is $27.36 and its two-hundred day moving average price is $24.09. The company has a market cap of $1.65 billion, a P/E ratio of -19.12 and a beta of 1.03.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Robert W. Baird dropped their price target on Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research note on Wednesday, December 11th. Piper Sandler reaffirmed an "overweight" rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Canaccord Genuity Group raised their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, March 13th. JMP Securities reiterated a "market outperform" rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and increased their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $31.33.

Insider Buying and Selling at Phreesia

In related news, SVP Amy Beth Vanduyn sold 1,311 shares of Phreesia stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now directly owns 115,633 shares in the company, valued at approximately $3,076,994.13. The trade was a 1.12 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $25.32, for a total value of $88,518.72. Following the completion of the transaction, the general counsel now owns 139,134 shares in the company, valued at approximately $3,522,872.88. This trade represents a 2.45 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 162,442 shares of company stock valued at $4,611,300. Company insiders own 5.80% of the company's stock.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.